Literature DB >> 30623910

Feasibility of robotic surgery in a developing country, a public sector Perspective.

Shahriyar Ghazanfar1, Sajida Qureshi1, Muhammad Zubair1, Umer Fateh2, Saif Ahmed2, Mohammad Saeed Quraishy1.   

Abstract

OBJECTIVE: To assess the clinical feasibility of robotic platform and to calculate cost for sustaining it..
METHODS: The study was conducted at Sindh Government Qatar Hospital and Civil Hospital Karachi from October 11, 2011, to August 30, 2017. Feasibility was assessed in terms of clinical outcome i.e. surgical complications, duration of stay and readmissions. The cost of doing an individual procedure was calculated along with the projected cost for 150, 200 and 250 cases per year. SPSS 23 was used for data analysis..
RESULTS: Of the 119 patients, 45(37.8%) were males and 74(62.2%) were females. Overall mean age was 42.10}13.40 years (range: 21-80 years. Mean hospital stay was 3.59}3 (range: 1-19 days). Complications occurred in 17(14.3%) patients ranging from wound infection 7(5.9%), bleeding 5(4.2%), intra-abdominal abscess 3(2.5%) and recurrence 2(1.7%). The total cost of robotic platform was Rs320 million with an annual maintenance contract of 10% of the total cost. The mean cost of performing a robotic procedure was Rs.389,263.05}39,249.63 (range: Rs252,823.09- Rs456,842.79)..
CONCLUSIONS: Robotic surgery was found to be a feasible and viable option. The major hindrance was the cost involved in setting up the system and recurring costs in terms of disposables.

Entities:  

Keywords:  Robotic surgery, Da Vinci robotic system, Da Vinci Si, Clinical feasibility, Financial implications.

Year:  2019        PMID: 30623910

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  1 in total

1.  Short term outcomes of three dimensional versus two-dimensional laparoscopic cholecystectomy.

Authors:  Abdul Razaque Shaikh; Aijaz Ahmed Shaikh; Mujib Abbasi
Journal:  Pak J Med Sci       Date:  2021 Jan-Feb       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.